Seven Eight Capital’s Medicines Co MDCO Stock Holding History

Seven Eight Capital’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-68,184	Closed	-$5.79M	–	820
2019 Q4	$5.79M	Buy	68,184 +23,441	+52%	+$1.56M	0.31%	90
2019 Q3	$2.24M	Buy	+44,743	New	+$1.78M	0.12%	262
2018 Q4	–	Sell	-20,300	Closed	-$607K	–	782
2018 Q3	$607K	Buy	+20,300	New	+$765K	0.04%	425
2017 Q2	–	Sell	-300	Closed	-$15K	–	724
2017 Q1	$15K	Buy	+300	New	+$13.7K	﹤0.01%	472
2016 Q1	–	Sell	-2,100	Closed	-$78K	–	730
2015 Q4	$78K	Buy	+2,100	New	+$79.4K	0.05%	393
2015 Q2	–	Sell	-4,700	Closed	-$132K	–	719
2015 Q1	$132K	Buy	+4,700	New	+$132K	0.22%	165

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Seven Eight Capital's MDCO Position: Q1 2020 in Review

Seven Eight Capital sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 68,184 shares — an estimated $5.79M sold.

Seven Eight Capital first reported a position in MDCO in Q1 2015 and held it in 6 quarters. The position peaked at $5.79M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Seven Eight Capital reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Seven Eight Capital sold 68,184 Medicines Co shares in Q1 2020, an estimated $5.79M.
Seven Eight Capital first reported a position in Medicines Co in Q1 2015 and held it in 6 quarters.
Seven Eight Capital's Medicines Co position peaked at $5.79M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Seven Eight Capital's 13F filing for Q1 2020, filed 14 May 2020.